의료용 튜브 시장 : 용도별, 소재별, 구조별, 지역별 - 세계 예측(-2031년)

The medical tubing market is expected to reach USD 19.64 billion by 2031 from USD 13.40 billion in 2026, at a CAGR of 7.9% during the forecast period.

The medical tubing market is experiencing rapid global growth, driven by rising healthcare demands and the need for safe, reliable, and high-quality fluid and gas transfer solutions. Key factors contributing to this market expansion include the rising prevalence of chronic diseases, advances in healthcare infrastructure, and the increasing use of minimally invasive surgical techniques.

Additionally, stringent regulations regarding patient safety and device effectiveness are pushing hospitals to adopt next-generation medical tubing systems. The heightened activity in the pharmaceutical and biotechnology sectors, along with the rising demand for single-use and disposable medical devices, is also a significant contributor to the overall growth of the market.

"Plastics are projected to be the second-largest material segment in the medical tubing market during the forecast period."

In the medical tubing market, plastics are expected to become the second-largest material segment. This is mainly due to their high performance, which arises from an excellent combination of flexibility, chemical resistance, and biocompatibility. Polyvinyl chloride (PVC) and polyethylene (PE) are two plastic materials that provide high mechanical strength and minimal moisture absorption, making them easy to process and suitable for a wide range of medical applications.

Plastic tubing is used in various settings, including IV infusion systems, blood transfusion lines, fluid delivery systems, and disposable medical products. It also plays a crucial role in drug development within the medical industry. Moreover, the large-scale production of plastic tubing, its resistance to sterilization methods, and its suitability for single-use medical items contribute to its growing demand in healthcare.

"Single-lumen tubing is projected to be the second-largest structure segment in the medical tubing market during the forecast period."

In the medical tubing market, single-lumen tubing is expected to become the second-largest segment due to its simple design, affordability, reliability, and versatility across various healthcare applications. Single-lumen tubing facilitates rapid, uniform fluid delivery, making it a common choice for IV infusion systems, drainage systems, respiratory devices, and basic catheterization procedures. Its straightforward design allows for easy production through multiple methods, and the materials used are widely accessible. This tubing is often used in high volumes for disposable medical devices, which is a key factor contributing to its popularity across various medical applications. Additionally, the growing trend toward purchasing more affordable single-use medical devices and fluid management solutions is likely to boost the demand for single-lumen tubing in the coming years.

"Catheters & cannulas are projected to be the largest application segment in the medical tubing market during the forecast period."

The catheters & cannulas segment is expected to be the largest application in the medical tubing market during the 2026-2031 forecast period. This is due to their use in both routine and critical medical procedures. Medical tubing in these applications provides a safe and reliable means of delivering or removing drugs, fluids, or gases within the human body.

Several factors are driving the growth of this segment, including the increase in chronic diseases, a rising number of surgical procedures, and a growing trend toward minimally invasive surgeries. Additionally, advancements in catheter and cannula design and materials, increased adoption of single-use medical tubing products, and rising demand for biocompatible materials are contributing to this segment's growth.

" North America is projected to be the second-largest regional segment in the medical tubing market during the forecast period."

North America is projected to be the second-largest market for medical tubing during the 2026-2031 forecast period. This growth is primarily due to the region's well-developed healthcare infrastructure and the widespread adoption of innovative medical technologies. Additionally, North America has a robust manufacturing industry for medical devices, increasing healthcare spending, and a rising demand for minimally invasive procedures.

Key factors driving market growth include the rising number of individuals affected by chronic illnesses, the expansion of home healthcare services, and a strong regulatory focus on patient safety and product quality. Moreover, the presence of leading medical device companies in both the United States and Canada, along with ongoing investments in research and development and advanced polymer technologies, further enhances North America's dominance in the global medical tubing market.

By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)

By Designation: Directors (30%), Managers (20%), and Others (50%)

By Region: North America (20%), Europe (10%), Asia Pacific (40%), South America (10%), and the Middle East & Africa (20%)

Note 1: Others include sales, marketing, and product managers.

Note 2: Tier 1: >USD 1 Billion; Tier 2: USD 500 million-1 Billion; and Tier 3: <USD 500 million

Companies Covered: Saint-Gobain (France), Freudenberg Medical (US), W. L. Gore & Associates, Inc. (US), The Lubrizol Corporation (US), Nordson Corporation (US), TE Connectivity (Switzerland), Elkem ASA (Norway), Trelleborg AB (Sweden), RAUMEDIC AG (Germany), and Teknor Apex (US).

The study includes an in-depth competitive analysis of these key players in the medical tubing market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the medical tubing market based on material (plastics, rubbers, specialty polymers), structure (single-lumen tubing, multi-lumen tubing, co-extruded tubing, tapered or bump tubing, braided tubing), and application (bulk disposable tubing, catheters & cannulas, drug delivery systems, other applications). The report's scope covers detailed information regarding drivers, restraints, challenges, and opportunities influencing the growth of the medical tubing market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products offered, and key strategies, such as mergers, acquisitions, product launches, and expansions, associated with the medical tubing market. This report covers a competitive analysis of upcoming startups in the medical tubing market ecosystem.

Reasons to Buy the Report

The report will provide market leaders/new entrants with the closest approximations of revenue numbers for the overall medical tubing market and its subsegments. This report will help stakeholders understand the competitive landscape, gain deeper insights into how to better position their businesses, and plan suitable go-to-market strategies. The report will help stakeholders understand the market pulse and provide information on key drivers, restraints, challenges, and opportunities.

The report provides insights into the following points:

• Analysis of key drivers (growing geriatric population, increasing demand for minimally invasive medical procedures, advancements in extrusion technology, and stringent quality standards and regulations), restraints (limited material compatibility and environmental and disposal concerns), opportunities (advancements in biocompatible and smart materials and increasing governmental expenditure for upgrading and developing healthcare infrastructure), and challenges (high production costs and marketing complexities).
• Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and product & service launches in the medical tubing market.
• Market Development: Comprehensive information about profitable markets; the report analyzes the medical tubing market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the medical tubing market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Saint-Gobain (France), Freudenberg Medical (US), W. L. Gore & Associates, Inc. (US), The Lubrizol Corporation (US), Nordson Corporation (US), TE Connectivity (Switzerland), Elkem ASA (Norway), Trelleborg AB (Sweden), RAUMEDIC AG (Germany), and Teknor Apex (US), among others.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
  • 1.3.5 UNITS CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

• 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
• 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
• 2.3 DISRUPTIVE TRENDS SHAPING MEDICAL TUBING MARKET
• 2.4 HIGH-GROWTH SEGMENTS
• 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

• 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL TUBING MARKET
• 3.2 MEDICAL TUBING MARKET, BY MATERIAL
• 3.3 MEDICAL TUBING MARKET, BY STRUCTURE
• 3.4 MEDICAL TUBING MARKET, BY APPLICATION
• 3.5 MEDICAL TUBING MARKET, BY REGION

4 MARKET OVERVIEW

• 4.1 INTRODUCTION
• 4.2 MARKET DYNAMICS
  • 4.2.1 DRIVERS
    • 4.2.1.1 Growing aging population and chronic diseases
    • 4.2.1.2 Increasing healthcare infrastructure investments
    • 4.2.1.3 Increasing demand for minimally invasive medical procedures
    • 4.2.1.4 Advancements in extrusion technology
    • 4.2.1.5 Stringent quality standards and regulations
  • 4.2.2 RESTRAINTS
    • 4.2.2.1 Limited material compatibility
    • 4.2.2.2 Environmental and disposal concerns
  • 4.2.3 OPPORTUNITIES
    • 4.2.3.1 Advancements in biocompatible and smart materials
    • 4.2.3.2 Expansion of medical tourism and high-end healthcare facilities
  • 4.2.4 CHALLENGES
    • 4.2.4.1 High production costs and marketing complexities
• 4.3 UNMET NEEDS AND WHITE SPACES
  • 4.3.1 UNMET NEEDS IN MEDICAL TUBING MARKET
  • 4.3.2 WHITE SPACE OPPORTUNITIES
• 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
  • 4.4.1 INTERCONNECTED MARKETS
  • 4.4.2 CROSS-SECTOR OPPORTUNITIES
• 4.5 EMERGING BUSINESS MODELS AND ECOSYSTEM SHIFTS
  • 4.5.1 EMERGING BUSINESS MODELS
  • 4.5.2 ECOSYSTEM SHIFTS
• 4.6 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
  • 4.6.1 KEY MOVES AND STRATEGIC FOCUS
• 4.7 PORTER'S FIVE FORCES ANALYSIS
  • 4.7.1 THREAT OF NEW ENTRANTS
  • 4.7.2 THREAT OF SUBSTITUTES
  • 4.7.3 BARGAINING POWER OF SUPPLIERS
  • 4.7.4 BARGAINING POWER OF BUYERS
  • 4.7.5 INTENSITY OF COMPETITIVE RIVALRY

5 INDUSTRY TRENDS

• 5.1 INTRODUCTION
• 5.2 VALUE CHAIN ANALYSIS
• 5.3 REGULATORY LANDSCAPE
  • 5.3.1 REGULATIONS
    • 5.3.1.1 North America
    • 5.3.1.2 Asia Pacific
    • 5.3.1.3 Europe
  • 5.3.2 STANDARDS
    • 5.3.2.1 ISO standard
    • 5.3.2.2 Food and Drug Administration (FDA)
    • 5.3.2.3 ASTM (American Society for Testing and Materials) standards
  • 5.3.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.4 TRADE ANALYSIS
  • 5.4.1 IMPORT SCENARIO (HS CODE 3917)
  • 5.4.2 EXPORT SCENARIO (HS CODE 3917)
• 5.5 ECOSYSTEM ANALYSIS
• 5.6 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.7 CASE STUDY ANALYSIS
  • 5.7.1 FREUDENBERG MEDICAL TO PROVIDE SPECIALTY BALLOON CATHETERS
  • 5.7.2 W. L. GORE & ASSOCIATES, INC. PROVIDES GORE STA-PURE PUMP TUBING

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

• 6.1 TECHNOLOGY ANALYSIS
  • 6.1.1 KEY TECHNOLOGIES
    • 6.1.1.1 Extrusion technology
    • 6.1.1.2 Advanced material technologies
  • 6.1.2 COMPLEMENTARY TECHNOLOGIES
    • 6.1.2.1 Smart technologies and connectivity
    • 6.1.2.2 Surface treatment and modification
• 6.2 KEY CONFERENCES AND EVENTS, 2026-2027
• 6.3 PATENT ANALYSIS
  • 6.3.1 METHODOLOGY
  • 6.3.2 DOCUMENT TYPES
  • 6.3.3 PUBLICATION TRENDS IN LAST 10 YEARS
  • 6.3.4 INSIGHTS
  • 6.3.5 LEGAL STATUS OF PATENTS
  • 6.3.6 JURISDICTION ANALYSIS
  • 6.3.7 TOP APPLICANTS
• 6.4 FUTURE APPLICATIONS
  • 6.4.1 ADVANCED, MINIMALLY INVASIVE, AND ROBOTIC SURGERY
  • 6.4.2 CARDIOVASCULAR AND NEUROVASCULAR INTERVENTIONS
  • 6.4.3 CELL AND GENE THERAPY
  • 6.4.4 SUSTAINABLE MEDICAL TUBING
• 6.5 IMPACT OF AI/GEN AI ON MEDICAL TUBING MARKET
• 6.6 PRICING ANALYSIS
  • 6.6.1 AVERAGE SELLING PRICE, BY REGION, 2022-2025
  • 6.6.2 AVERAGE SELLING PRICE FOR TOP THREE APPLICATIONS, BY KEY PLAYER, 2025
  • 6.6.3 AVERAGE SELLING PRICE TREND, BY MATERIAL, 2022-2025
• 6.7 INVESTMENT AND FUNDING SCENARIO
• 6.8 ADOPTION BARRIERS & INTERNAL CHALLENGES
• 6.9 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
• 6.10 MARKET PROFITABILITY
  • 6.10.1 REVENUE POTENTIAL
  • 6.10.2 COST DYNAMICS
  • 6.10.3 MARGIN OPPORTUNITIES IN KEY END-USE SECTORS

7 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

• 7.1 INTRODUCTION
• 7.2 DECISION-MAKING PROCESS
• 7.3 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 7.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 7.3.2 BUYING CRITERIA
• 7.4 MACROECONOMIC INDICATORS
  • 7.4.1 HEALTHCARE EXPENDITURES
• 7.5 IMPACT OF 2025 US TARIFF - OVERVIEW
  • 7.5.1 INTRODUCTION
  • 7.5.2 KEY TARIFF RATES
  • 7.5.3 PRICE IMPACT ANALYSIS
  • 7.5.4 IMPACT ON COUNTRY/REGION
    • 7.5.4.1 US
    • 7.5.4.2 Europe
    • 7.5.4.3 Asia Pacific
  • 7.5.5 IMPACT ON END-USE INDUSTRIES

8 MEDICAL TUBING MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 BULK DISPOSABLE TUBING
  • 8.2.1 DEMAND FROM HOSPITALS, HOME HEALTHCARE PROVIDERS, AND EMERGENCY CARE PROVIDERS TO BOOST MARKET
  • 8.2.2 DIALYSIS TUBING
    • 8.2.2.1 Growing aging population to drive demand
  • 8.2.3 INTRAVENOUS TUBING
    • 8.2.3.1 Technological advancements to drive market
• 8.3 CATHETERS & CANNULAS
  • 8.3.1 RISING CARDIOVASCULAR DISEASES AND DEMAND FOR MINIMALLY INVASIVE SURGICAL PROCEDURES TO DRIVE MARKET
  • 8.3.2 CATHETERS
    • 8.3.2.1 Increase in chronic diseases contributing to significant demand
    • 8.3.2.2 Cardiovascular catheters
      • 8.3.2.2.1 Growing elderly population and high incidence of cardiovascular diseases to drive market
    • 8.3.2.3 IV catheters
      • 8.3.2.3.1 Demand for direct delivery of medication and nutrients into bloodstream to fuel growth
    • 8.3.2.4 Urinary catheters
      • 8.3.2.4.1 Rising incidences of urinary tract infections and growing need for advanced technologies to drive demand
  • 8.3.3 CANNULAS
    • 8.3.3.1 Evolving healthcare sector and stringent regulatory requirements to support market growth
• 8.4 DRUG DELIVERY SYSTEMS
  • 8.4.1 PRECISE DRUG DELIVERY TO TARGET SITES TO DRIVE DEMAND
  • 8.4.2 NASOGASTRIC
    • 8.4.2.1 Need for enteral feeding and drainage to fuel demand
  • 8.4.3 NEBULIZERS
    • 8.4.3.1 Conversion of liquid medications to mists for inhalation to drive market
• 8.5 OTHER APPLICATIONS
  • 8.5.1 PERISTALTIC PUMP TUBING
    • 8.5.1.1 Wide demand for minimizing contamination to boost market
  • 8.5.2 GAS SUPPLY TUBING
    • 8.5.2.1 Increasing minimally invasive surgeries to support market growth
  • 8.5.3 SMOKE EVACUATION TUBING
    • 8.5.3.1 Popularity of cosmetic procedures and medical tourism to drive market

9 MEDICAL TUBING MARKET, BY MATERIAL

• 9.1 INTRODUCTION
• 9.2 PLASTICS
  • 9.2.1 BIOCOMPATIBILITY, CHEMICAL STABILITY, AND COST-EFFECTIVENESS TO BOOST MARKET
  • 9.2.2 POLYVINYL CHLORIDE (PVC)
  • 9.2.3 POLYOLEFIN
    • 9.2.3.1 Polyethylene (PE)
    • 9.2.3.2 Polypropylene (PP)
  • 9.2.4 POLYAMIDE
  • 9.2.5 POLYTETRAFLUOROETHYLENE (PTFE)
  • 9.2.6 POLYETHER ETHER KETONE (PEEK)
  • 9.2.7 POLYCARBONATE (PC)
• 9.3 RUBBERS
  • 9.3.1 SIGNIFICANT DURABILITY AND RESILIENCE TO DRIVE DEMAND
  • 9.3.2 THERMOPLASTIC ELASTOMER (TPE)
  • 9.3.3 THERMOPLASTIC POLYURETHANE (TPU)
  • 9.3.4 SILICONE
  • 9.3.5 POLYURETHANE (PU)
  • 9.3.6 ETHYLENE PROPYLENE DIENE MONOMER (EPDM)
  • 9.3.7 LATEX
• 9.4 SPECIALTY POLYMERS
  • 9.4.1 BIOABSORBABLE POLYMERS
  • 9.4.2 ETHYLENE VINYL ACETATE (EVA)
• 9.5 OTHER MATERIALS

10 MEDICAL TUBING MARKET, BY STRUCTURE

• 10.1 INTRODUCTION
• 10.2 SINGLE-LUMEN
  • 10.2.1 DEMAND FOR ADMINISTRATION OF FLUIDS AND MEDICATION, AIRWAY MANAGEMENT, AND PATIENT NUTRITION TO DRIVE MARKET
• 10.3 CO-EXTRUDED
  • 10.3.1 DURABILITY, LUBRICITY, OPACITY, RADIOPACITY, AND TENSILE STRENGTH TO BOOST MARKET
• 10.4 MULTI-LUMEN
  • 10.4.1 NON-TOXICITY, BIOCOMPATIBILITY, AND INERTNESS TO FUEL MARKET DEMAND
• 10.5 TAPERED OR BUMP TUBING
  • 10.5.1 ENHANCED FUNCTIONALITIES IN CVC, PICC, AND DRUG DELIVERY CATHETERS TO DRIVE MARKET
• 10.6 BRAIDED TUBING
  • 10.6.1 GOOD STRENGTH, STEERABILITY, AND PRESSURE RESISTANCE TO DRIVE MARKET

11 MEDICAL TUBING MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 US
    • 11.2.1.1 High disposable income and strong healthcare infrastructure to drive market
  • 11.2.2 CANADA
    • 11.2.2.1 Aging population and increasing healthcare expenditure to support market growth
  • 11.2.3 MEXICO
    • 11.2.3.1 High investments and low manufacturing costs to fuel demand
• 11.3 EUROPE
  • 11.3.1 GERMANY
    • 11.3.1.1 Advanced medical facilities and R&D investments to drive market
  • 11.3.2 FRANCE
    • 11.3.2.1 Rising elderly population to fuel market growth
  • 11.3.3 UK
    • 11.3.3.1 Innovation, technological advancements, and investments to drive market
  • 11.3.4 SPAIN
    • 11.3.4.1 Growing aging population and improvements in healthcare system to increase consumption
  • 11.3.5 ITALY
    • 11.3.5.1 Growing geriatric population and strong focus on research and innovation to drive market
  • 11.3.6 NETHERLANDS
    • 11.3.6.1 Rising home care treatment to increase demand
  • 11.3.7 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 CHINA
    • 11.4.1.1 Investments in manufacturing medical devices to support market
  • 11.4.2 JAPAN
    • 11.4.2.1 Japan's aging population increases demand for medical tubing
  • 11.4.3 INDIA
    • 11.4.3.1 Government initiatives, high purchasing power, and rising manufacturing output to fuel demand
  • 11.4.4 SOUTH KOREA
    • 11.4.4.1 Medical tourism to lead to market growth
  • 11.4.5 REST OF ASIA PACIFIC
• 11.5 MIDDLE EAST & AFRICA
  • 11.5.1 GCC COUNTRIES
    • 11.5.1.1 Saudi Arabia
      • 11.5.1.1.1 Government initiatives to support market growth
    • 11.5.1.2 UAE
      • 11.5.1.2.1 Government funding and rapidly developing private health sector to drive market
    • 11.5.1.3 Rest of GCC
      • 11.5.1.3.1 Government funding and rapidly developing private health sector to drive market
  • 11.5.2 SOUTH AFRICA
    • 11.5.2.1 Growing healthcare sector to drive market
  • 11.5.3 EGYPT
    • 11.5.3.1 Technological advancements and improving healthcare sector to fuel demand
  • 11.5.4 REST OF MIDDLE EAST & AFRICA
• 11.6 SOUTH AMERICA
  • 11.6.1 BRAZIL
    • 11.6.1.1 Demographic shifts coupled with increasing investments in healthcare sector to drive market
  • 11.6.2 ARGENTINA
    • 11.6.2.1 Growing aging population to drive market
  • 11.6.3 REST OF SOUTH AMERICA

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020-2026
• 12.3 REVENUE ANALYSIS, 2025
• 12.4 MARKET SHARE ANALYSIS, 2025
• 12.5 COMPANY VALUATION AND FINANCIAL METRICS
• 12.6 BRAND COMPARISON
  • 12.6.1 BIO-SIL TUBING
  • 12.6.2 HELIXFLEX
  • 12.6.3 ISOPLAST ETPU MEDICAL TUBING
  • 12.6.4 GORE STA-PURE PUMP TUBING SERIES PFL
• 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
  • 12.7.1 STARS
  • 12.7.2 EMERGING LEADERS
  • 12.7.3 PERVASIVE PLAYERS
  • 12.7.4 PARTICIPANTS
  • 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
    • 12.7.5.1 Company footprint
    • 12.7.5.2 Region footprint
    • 12.7.5.3 Structure footprint
    • 12.7.5.4 Material footprint
    • 12.7.5.5 Application footprint
• 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
  • 12.8.1 PROGRESSIVE COMPANIES
  • 12.8.2 RESPONSIVE COMPANIES
  • 12.8.3 DYNAMIC COMPANIES
  • 12.8.4 STARTING BLOCKS
  • 12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
    • 12.8.5.1 Detailed list of key startups/SMEs
    • 12.8.5.2 Competitive benchmarking of startups/SMEs
• 12.9 COMPETITIVE SCENARIO
  • 12.9.1 PRODUCT LAUNCHES
  • 12.9.2 DEALS
  • 12.9.3 OTHER DEVELOPMENTS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 SAINT-GOBAIN
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products/Solutions/Services offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Deals
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Right to win
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses and competitive threats
  • 13.1.2 FREUDENBERG MEDICAL
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products/Solutions/Services offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Product launches
      • 13.1.2.3.2 Deals
      • 13.1.2.3.3 Expansions
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Right to win
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses and competitive threats
  • 13.1.3 THE LUBRIZOL CORPORATION
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products/Solutions/Services offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Deals
      • 13.1.3.3.2 Expansions
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Right to win
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses and competitive threats
  • 13.1.4 W. L. GORE & ASSOCIATES, INC.
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products/Solutions/Services offered
    • 13.1.4.3 MnM view
      • 13.1.4.3.1 Right to win
      • 13.1.4.3.2 Strategic choices
      • 13.1.4.3.3 Weaknesses and competitive threats
  • 13.1.5 NORDSON CORPORATION
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products/Solutions/Services offered
    • 13.1.5.3 Recent developments
      • 13.1.5.3.1 Product launches
      • 13.1.5.3.2 Deals
    • 13.1.5.4 MnM view
      • 13.1.5.4.1 Right to win
      • 13.1.5.4.2 Strategic choices
      • 13.1.5.4.3 Weaknesses and competitive threats
  • 13.1.6 TE CONNECTIVITY
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products/Solutions/Services offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Product launches
    • 13.1.6.4 MnM view
  • 13.1.7 ELKEM ASA
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products/Solutions/Services offered
    • 13.1.7.3 Recent developments
      • 13.1.7.3.1 Deals
      • 13.1.7.3.2 Expansions
    • 13.1.7.4 MnM view
  • 13.1.8 TRELLEBORG AB
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products/Solutions/Services offered
    • 13.1.8.3 Recent developments
      • 13.1.8.3.1 Deals
      • 13.1.8.3.2 Other developments
    • 13.1.8.4 MnM view
  • 13.1.9 RAUMEDIC AG
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products/Solutions/Services offered
    • 13.1.9.3 Recent developments
      • 13.1.9.3.1 Product launches
      • 13.1.9.3.2 Deals
      • 13.1.9.3.3 Expansions
    • 13.1.9.4 MnM view
  • 13.1.10 SPECTRUM PLASTICS GROUP
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products/Solutions/Services offered
    • 13.1.10.3 Recent developments
      • 13.1.10.3.1 Deals
      • 13.1.10.3.2 Expansions
    • 13.1.10.4 MnM view
  • 13.1.11 ZEUS COMPANY LLC
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products/Solutions/Services offered
    • 13.1.11.3 Recent developments
      • 13.1.11.3.1 Product launches
      • 13.1.11.3.2 Expansions
    • 13.1.11.4 MnM view
• 13.2 OTHER PLAYERS
  • 13.2.1 ATAG SPA
  • 13.2.2 DAVIS STANDARD
  • 13.2.3 FBK MEDICAL TUBING
  • 13.2.4 PROTERIAL CABLE AMERICA, INC.
  • 13.2.5 ICO RALLY
  • 13.2.6 ICU MEDICAL, INC.
  • 13.2.7 KRATON CORPORATION
  • 13.2.8 MICROLUMEN INC.
  • 13.2.9 MDC INDUSTRIES
  • 13.2.10 NEWAGE INDUSTRIES
  • 13.2.11 OPTINOVA
  • 13.2.12 PARKER HANNIFIN CORP.
  • 13.2.13 TEEL PLASTICS
  • 13.2.14 VESTA INC.
  • 13.2.15 SMOOTH-BOR PLASTICS

14 RESEARCH METHODOLOGY

• 14.1 RESEARCH DATA
  • 14.1.1 SECONDARY DATA
    • 14.1.1.1 List of key secondary sources
    • 14.1.1.2 Key data from secondary sources
  • 14.1.2 PRIMARY DATA
    • 14.1.2.1 Key data from primary sources
    • 14.1.2.2 List of primary interview participants-demand and supply side
    • 14.1.2.3 Key industry insights
    • 14.1.2.4 Breakdown of interviews with experts
• 14.2 MARKET SIZE ESTIMATION
  • 14.2.1 BOTTOM-UP APPROACH
  • 14.2.2 TOP-DOWN APPROACH
• 14.3 DATA TRIANGULATION
• 14.4 ASSUMPTIONS
• 14.5 LIMITATIONS AND RISKS

15 APPENDIX

• 15.1 DISCUSSION GUIDE
• 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 15.3 CUSTOMIZATION OPTIONS
• 15.4 RELATED REPORTS
• 15.5 AUTHOR DETAILS